Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diastolic Deceleration Area (DDA) in Late-onset Fetal Growth Restriction (FGR)

NCT05837195 is registered in ClinicalTrials.gov with Orthogyn Medical Center, Bulgaria as lead sponsor.

NCT NCT05837195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05837195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diastolic Deceleration Area (DDA) in Late-onset Fetal Growth Restriction (FGR)
Lead sponsor
Orthogyn Medical Center, Bulgaria
Phase
Observational
Overall status
Unknown status
Start date
April 19, 2023
Completion date
June 30, 2024
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, hypoxia